Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients

By sjmartinez • July 12, 2024

Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 Jun 29;68:152504. doi: 10.1016/j.semarthrit.2024.152504. Epub ahead of print. PMID: 38991379.

Tags: biological therapy, cardiovascular diseases, lipoprotein, Publications, Rheumatoid arthritis, Rheumatology

Xenium spatial transcriptomics identifies mesenchymal fibroblast expansion and conserved fibrotic ECM programs in keloid

Deng M, Brewer GM, Espinoza A, Orellana-Montes J, Hedayatyanfard K, Hu C, Jahan MGS, Deriss M, Davis JC, Cheng CE, Pellegrini M, Agak GW. Xenium[...]

Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB-IIIA Non-Small Cell Lung Cancer: Exploratory 8-year Overall Survival Landmark Update from the ADAURA Trial [161/175]

Wu YL, Majem M, John T, Grohé C, Wang J, Goldman JW, Lu S, Shepherd FA, Wang Q, Kato T, Aokage K, Zhong WZ, Laktionov[...]

The latest Fontan paradox: when less is more (difficult)

Moore JP, Paul T, Etheridge SP. The latest Fontan paradox: when less is more (difficult). Europace. 2026 Sep 2;28(9):euag239. doi: 10.1093/europace/euag239. PMID: 42732894; PMCID: PMC13571844.